| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.22 | 0.5 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 8e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |